AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 14

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.07 % area, n=556. Read the 2025-Q2 state-of-the-index report →

556 records14 pagesmedian on this page 99.41 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019678RetatrutideHomopeptideHOMO-2412-V2760Medutest2025-Q297.694.0694.6Supplier-supplied1MARGINAL
AX-2025-019487GHRP-6HomopeptideHOMO-2504-G9629Janoshik2025-Q299.453.92—Supplier-supplied1MARGINAL
AX-2025-019326MK-677 (Ibutamoren mesylate)TFCTFC-2505-N7258Medutest2025-Q298.945.7489.8Supplier-supplied3FAIL
AX-2025-021039SurvodutideWXTWXT-2501-X3943Janoshik2025-Q298.324.0796.3Supplier-supplied1MARGINAL
AX-2025-020967TB-500CPCCPC-2411-X2935Janoshik2025-Q299.723.12—Supplier-supplied3MARGINAL
AX-2025-020209BPC-157GGPepsGGPE-2411-V1398PeptideMeter2025-Q298.763.7799.3Supplier-supplied2MARGINAL
AX-2025-019974BPC-157SWBSWB-2504-M6687Janoshik2025-Q299.914.50100.9Supplier-supplied0PASS
AX-2025-018976KPVFGPFGP-2501-A1918Kestrel2025-Q299.932.79—Laboratory-retained0PASS
AX-2025-018675GHRP-6QYBQYB-2504-H5763Nordanalyt2025-Q299.616.2093.0Supplier-supplied1MARGINAL
AX-2025-018553TB-500WWBWWB-2501-Y4287Janoshik2025-Q299.933.47—Supplier-supplied2MARGINAL
AX-2025-019823AOD-9604HJHJ-2412-V4024Janoshik2025-Q298.783.34—Supplier-supplied2MARGINAL
AX-2025-019071TirzepatideJEEPJEEP-2412-U3223Janoshik2025-Q299.482.91—Supplier-supplied1MARGINAL
AX-2025-018782TB-500QSCQSC-2504-T7980Janoshik2025-Q299.934.00—Supplier-supplied0PASS
AX-2025-020766TriptorelinSGNSGN-2504-A9926PeptideMeter2025-Q298.734.8199.0Supplier-supplied1MARGINAL
AX-2025-019888RetatrutideSWBSWB-2503-P4938Janoshik2025-Q298.245.01—Supplier-supplied2MARGINAL
AX-2025-019857IpamorelinSWBSWB-2501-Y4965Janoshik2025-Q299.884.2088.5Supplier-supplied3MARGINAL
AX-2025-019299ARA-290TFCTFC-2501-K7199VendorInvestigate2025-Q299.335.31—Buyer-sourced1MARGINAL
AX-2025-018785TB-500QSCQSC-2504-T7980Janoshik2025-Q299.933.11—Supplier-supplied0PASS
AX-2025-020319SurvodutideMKMMKM-2411-E3058Medutest2025-Q297.925.25—Supplier-supplied1MARGINAL
AX-2025-019543SemaglutideHomopeptideHOMO-2501-A1307Kestrel2025-Q299.936.1492.2Buyer-sourced2FAIL
AX-2025-019492GHRP-6HomopeptideHOMO-2504-G9629Janoshik2025-Q299.622.8893.2Supplier-supplied1MARGINAL
AX-2025-021228HexarelinBCHBCH-2501-B6879VendorInvestigate2025-Q297.635.65103.9Buyer-sourced2FAIL
AX-2025-018786TB-500QSCQSC-2504-T7980Janoshik2025-Q299.803.82—Supplier-supplied1MARGINAL
AX-2025-021035SurvodutideWXTWXT-2501-X3943Janoshik2025-Q298.213.59101.4Supplier-supplied1MARGINAL
AX-2025-020177KPVGGPepsGGPE-2411-R9751Nordanalyt2025-Q298.315.58—Supplier-supplied0FAIL
AX-2025-019327MK-677 (Ibutamoren mesylate)TFCTFC-2505-N7258Janoshik2025-Q299.486.17105.1Supplier-supplied2FAIL
AX-2025-019094GHRP-6JEEPJEEP-2503-B3455Janoshik2025-Q299.875.40—Supplier-supplied1MARGINAL
AX-2025-021225HexarelinBCHBCH-2501-B6879Janoshik2025-Q297.565.75—Laboratory-retained2FAIL
AX-2025-020186KPVGGPepsGGPE-2411-R9751PeptideMeter2025-Q298.434.83—Buyer-sourced0FAIL
AX-2025-019083TirzepatideJEEPJEEP-2412-U3223PeptideMeter2025-Q299.502.4898.5Supplier-supplied1MARGINAL
AX-2025-018555TB-500WWBWWB-2501-Y4287Janoshik2025-Q299.373.46—Supplier-supplied2MARGINAL
AX-2025-018430NAD+WWBWWB-2504-B2388Nordanalyt2025-Q299.7011.55—Supplier-supplied1FAIL
AX-2025-020220TirzepatideGGPepsGGPE-2412-M1040PeptideMeter2025-Q298.013.87103.7Supplier-supplied1MARGINAL
AX-2025-020026Kisspeptin-10ERPERP-2504-G6947Janoshik2025-Q299.315.3798.1Supplier-supplied1MARGINAL
AX-2025-020374RetatrutideMKMMKM-2504-F3495Janoshik2025-Q298.367.1990.6Supplier-supplied1MARGINAL
AX-2025-018671N-Acetyl Semax AmideQYBQYB-2501-C5919Medutest2025-Q299.936.21—Supplier-supplied0PASS